Literature DB >> 22898046

Knockdown of pre-mRNA cleavage factor Im 25 kDa promotes neurite outgrowth.

Hidefumi Fukumitsu1, Hitomi Soumiya, Shoei Furukawa.   

Abstract

Mammalian precursor mRNA (pre-mRNA) cleavage factor I (CFIm) plays important roles in the selection of poly(A) sites in a 3'-untranslated region (3'-UTR), producing mRNAs with variable 3' ends. Because 3'-UTRs often contain cis elements that impact stability or localization of mRNA or translation, alternative polyadenylation diversifies utilization of primary transcripts in mammalian cells. However, the physiological role of CFIm remains unclear. CFIm acts as a heterodimer comprising a 25kDa subunit (CFIm25) and one of the three large subunits-CFIm59, CFIm68, or CFIm72. CFIm25 binds directly to RNA and introduces and anchors the larger subunit. To examine the physiological roles of CFIm, we knocked down the CFIm25 gene in neuronal cells using RNA interference. Knockdown of CFIm25 increased the number of primary dendrites of developing hippocampal neurons and promoted nerve growth factor (NGF)-induced neurite extension from rat pheochromocytoma PC12 cells without affecting the morphology of proliferating PC12 cells. On the other hand, CFIm25 knockdown did not influence constitutively active or dominantly negative RhoA suppression or promotion of NGF-induced neurite extension from PC12 cells, respectively. Taken together, our results indicate that endogenous CFIm may promote neuritogenesis in developing neurons by coordinating events upstream of NGF-induced RhoA inactivation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898046     DOI: 10.1016/j.bbrc.2012.07.164

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Silencing the cleavage factor CFIm25 as a new strategy to control Entamoeba histolytica parasite.

Authors:  Juan David Ospina-Villa; Nancy Guillén; Cesar Lopez-Camarillo; Jacqueline Soto-Sanchez; Esther Ramirez-Moreno; Raul Garcia-Vazquez; Carlos A Castañon-Sanchez; Abigail Betanzos; Laurence A Marchat
Journal:  J Microbiol       Date:  2017-09-28       Impact factor: 3.422

2.  Polyadenylation site-specific differences in the activity of the neuronal βCstF-64 protein in PC-12 cells.

Authors:  Ganesh S Shankarling; Clinton C MacDonald
Journal:  Gene       Date:  2013-08-12       Impact factor: 3.688

3.  Priming with FGF2 stimulates human dental pulp cells to promote axonal regeneration and locomotor function recovery after spinal cord injury.

Authors:  Kosuke Nagashima; Takahiro Miwa; Hitomi Soumiya; Daisuke Ushiro; Tomoko Takeda-Kawaguchi; Naritaka Tamaoki; Saho Ishiguro; Yumi Sato; Kei Miyamoto; Takatoshi Ohno; Masatake Osawa; Takahiro Kunisada; Toshiyuki Shibata; Ken-Ichi Tezuka; Shoei Furukawa; Hidefumi Fukumitsu
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

Review 4.  Tissue-specific mechanisms of alternative polyadenylation: Testis, brain, and beyond (2018 update).

Authors:  Clinton C MacDonald
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-02-27       Impact factor: 9.957

5.  The 25 kDa subunit of cleavage factor Im Is a RNA-binding protein that interacts with the poly(A) polymerase in Entamoeba histolytica.

Authors:  Marisol Pezet-Valdez; Jorge Fernández-Retana; Juan David Ospina-Villa; María Esther Ramírez-Moreno; Esther Orozco; Socorro Charcas-López; Jacqueline Soto-Sánchez; Guillermo Mendoza-Hernández; Mavil López-Casamicha; César López-Camarillo; Laurence A Marchat
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

6.  CFIm25 inhibits hepatocellular carcinoma metastasis by suppressing the p38 and JNK/c-Jun signaling pathways.

Authors:  Yunwu Wang; Yu Xu; Wei Yan; Ping Han; Jingmei Liu; Jin Gong; Dongxiao Li; Xiangming Ding; Han Wang; Zhuoying Lin; Dean Tian; Jiazhi Liao
Journal:  Oncotarget       Date:  2018-01-31

7.  Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.

Authors:  Tingting Weng; Jingjing Huang; Eric J Wagner; Junsuk Ko; Minghua Wu; Nancy E Wareing; Yu Xiang; Ning-Yuan Chen; Ping Ji; Jose G Molina; Kelly A Volcik; Leng Han; Maureen D Mayes; Michael R Blackburn; Shervin Assassi
Journal:  J Exp Med       Date:  2020-02-03       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.